Imiquimod Immunology & Inflammation related chemical

Cat.No.S1211

Imiquimod is a novel synthetic agent with immune response modifying activity.
Imiquimod Immunology & Inflammation related chemical Chemical Structure

Chemical Structure

Molecular Weight: 240.3

Quality Control

Chemical Information, Storage & Stability

Molecular Weight 240.3 Formula

C14H16N4

Storage (From the date of receipt)
CAS No. 99011-02-6 Download SDF Storage of Stock Solutions

Synonyms R-837, S-26308 Smiles CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N

Solubility

In vitro
Batch:

DMSO : 2 mg/mL (8.32 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Applications

Methods Biomarkers Images PMID
Growth inhibition assay Cell viability S1211-viability1 24743316
Western blot PARP S1211-WB1 24743316

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06252857 Recruiting
Basal Cell Carcinoma
Maastricht University Medical Center
April 22 2024 --
NCT06052696 Not yet recruiting
Vulvar HSIL|HPV
Erasmus Medical Center|Dutch Cancer Society
December 1 2023 Phase 4
NCT05838599 Recruiting
Mycosis Fungoides
Northwestern University
July 24 2023 Early Phase 1
NCT05315024 Unknown status
Influenza
The University of Hong Kong
April 30 2022 Not Applicable
NCT04883645 Active not recruiting
Oral Cancer
Medical University of South Carolina
April 28 2022 Early Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.